European Stocks Trim Monthly Gain as Novo Nordisk and UMG Slump
European stocks retreated slightly on Friday as pharmaceutical company Novo Nordisk's decline offset broader market strength in the technology sector. Despite the setback, the market maintained most of its monthly gains as companies continued to report largely positive earnings results.
1 Article
Trace's outlet lean is shown first — tap Left / Center / Right on each source to add your rating too.
- BloombergTrace: Center
European Stocks Trim Monthly Gain as Novo Nordisk and UMG Slump
European stocks retreated slightly on Friday as pharmaceutical company Novo Nordisk's decline offset broader market strength in the technology sector. Despite the setback, the market maintained most of its monthly gains as companies continued to report largely positive earnings results.
Rate outletRead original
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
Comments
0No comments yet. Say what you noticed in the coverage.
Trending